Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Cholangiocarcinoma is the second most common primary liver cancer, and its global incidence has increased in recent years. Radical surgical resection and systemic chemotherapy have traditionally been the standard treatment options. However, the complexity of cholangiocarcinoma subtypes often present...
Saved in:
| Main Authors: | Yunyan Dai, Chenyang Dong, Zhiming Wang, Yunpeng Zhou, Yi Wang, Yi Hao, Pinggui Chen, Chaojie Liang, Gaopeng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1482291/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of T cells in cholangiocarcinoma
by: Zhiming Wang, et al.
Published: (2025-02-01) -
Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
by: Bao Jin, et al.
Published: (2023-10-01) -
Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity
by: Yupeng Xu, et al.
Published: (2025-05-01) -
NCAPG2 is a diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
by: Zhaojun Huang, et al.
Published: (2025-05-01) -
PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
by: Jun Ye, et al.
Published: (2025-02-01)